Cardiovasc Prev Pharmacother > v.4(3)

4 results

95 Cardiovascular diseases in HIV patients
Hyun-Ha Chang
KMSID: 1516079390   Cardiovasc Prev Pharmacother. 2022;4(3):95-98.   Published online 2022 July 29    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e14
      
99 Blood pressure control in hypertensive disorders of pregnancy
Helsi Rismiati, Hae-Young Lee
KMSID: 1516079393   Cardiovasc Prev Pharmacother. 2022;4(3):99-105.   Published online 2022 July 29    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e16
      
106 Severe hypoglycemia as a risk factor for cardiovascular outcomes in patients with type 2 diabetes: is it preventable?
Seung-Hyun Ko
KMSID: 1516079391   Cardiovasc Prev Pharmacother. 2022;4(3):106-113.   Published online 2022 July 29    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e13
      
114 Effect of the addition of thiazolidinedione to sodium-glucose cotransporter 2 inhibitor therapy on lipid levels in type 2 diabetes mellitus: a retrospective study using Korean National Health Insurance Service data
Taegyun Park, Kyungdo Han, Dongwook Shin, Jongho Park
KMSID: 1516079392   Cardiovasc Prev Pharmacother. 2022;4(3):114-122.   Published online 2022 July 29    DOI: http://dx.doi.org/10.36011/cpp.2022.4.e15
      
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap